Skip Header

13 results for author:"Vajdos F.F." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (8)

Discovery and optimization of a novel spiropyrrolidine inhibitor of beta-secretase (BACE1) through fragment-based drug design.

Efremov I.V., Vajdos F.F., Borzilleri K.A., Capetta S., Chen H., Dorff P.H., Dutra J.K., Goldstein S.W., Mansour M., McColl A. et al.

J. Med. Chem. 55:9069-9088(2012) · Mapped (1)

Deconstruction of activity-dependent covalent modification of heme in human neutrophil myeloperoxidase by multistage mass spectrometry (MS(4)).

Geoghegan K.F., Varghese A.H., Feng X., Bessire A.J., Conboy J.J., Ruggeri R.B., Ahn K., Spath S.N., Filippov S.V., Conrad S.J. et al.

Biochemistry 51:2065-2077(2012) · Mapped (2)

Structure-guided inhibitor design for human acetyl-coenzyme A carboxylase by interspecies active site conversion.

Rajamohan F., Marr E., Reyes A.R., Landro J.A., Anderson M.D., Corbett J.W., Dirico K.J., Harwood J.H., Tu M., Vajdos F.F.

J. Biol. Chem. 286:41510-41519(2011) · Mapped (6)

The 2.0 A crystal structure of the ERalpha ligand-binding domain complexed with lasofoxifene.

Vajdos F.F., Hoth L.R., Geoghegan K.F., Simons S.P., LeMotte P.K., Danley D.E., Ammirati M.J., Pandit J.

Protein Sci. 16:897-905(2007) · Mapped (1)

Suppressor of fused regulates Gli activity through a dual binding mechanism.

Merchant M., Vajdos F.F., Ultsch M., Maun H.R., Wendt U., Cannon J., Desmarais W., Lazarus R.A., de Vos A.M., de Sauvage F.J.

Mol. Cell. Biol. 24:8627-8641(2004) · UniProtKB (1)

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.

Franklin M.C., Carey K.D., Vajdos F.F., Leahy D.J., de Vos A.M., Sliwkowski M.X.

Cancer Cell 5:317-328(2004) · UniProtKB (1)

Structural insights into the catalytic mechanism of cyclophilin A.

Howard B.R., Vajdos F.F., Li S., Sundquist W.I., Hill C.P.

Nat. Struct. Biol. 10:475-481(2003) · UniProtKB (1) · Mapped (2)

Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.

Vajdos F.F., Adams C.W., Breece T.N., Presta L.G., de Vos A.M., Sidhu S.S.

J. Mol. Biol. 320:415-428(2002) · Mapped (1)

Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions.

Vajdos F.F., Ultsch M., Schaffer M.L., Deshayes K.D., Liu J., Skelton N.J., de Vos A.M.

Biochemistry 40:11022-11029(2001) · Mapped (1)

Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein.

Vajdos F.F., Yoo S., Houseweart M., Sundquist W.I., Hill C.P.

Protein Sci. 6:2297-2307(1997) · UniProtKB (1)

Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.

Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Worthylake D.K., Wang H., McCutcheon J.P., Sundquist W.I., Hill C.P.

Science 278:849-853(1997) · UniProtKB (1)

Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.

Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., Hill C.P.

Cell 87:1285-1294(1996) · UniProtKB (1) · Mapped (1)

Pseudomonas cepacia 2,2-dialkylglycine decarboxylase. Sequence and expression in Escherichia coli of structural and repressor genes.

Keller J.W., Baurick K.B., Rutt G.C., O'Malley M.V., Sonafrank N.L., Reynolds R.A., Ebbesson L.O.E., Vajdos F.F.

J. Biol. Chem. 265:5531-5539(1990) · UniProtKB (3)

to top of page·

Page 1 of 1